UBS Assumes Neutral on Jasper Therapeutics, PT at $1.5

Monday, Mar 23, 2026 9:03 am ET1min read
JSPR--

UBS Assumes Neutral on Jasper Therapeutics, PT at $1.5

UBS Assumes Neutral on Jasper Therapeutics, PT at $1.5

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet